Floatz logo

Monomethyl Fumarate

Hematopoietic Cell Transplant Recipient

Fred Hutchinson Cancer CenterSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Hematopoietic Cell Transplant Recipient cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Fred Hutchinson Cancer Center
Phase 2B
Fludarabine
Fred Hutchinson Cancer Center
Phase 2B
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 2CCC
TACROLIMUS
Fred Hutchinson Cancer Center
Phase 2CCC
wt1-sensitized allogeneic t-lymphocytes
Fred Hutchinson Cancer Center
Phase 1/2CCC
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
City of Hope Medical Center
Phase 1CC

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →